ACMSY

AccuStem Sciences Limited [ACMSY] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

ACMSY Stock Summary

In the News

ACMSY Financial details

Company Rating
-
Market Cap
0
Income
-681.45M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-1.56
P/C
-
P/FCF
-
Quick Ratio
0.15
Current Ratio
0.2
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-61.85
EPS next Y
-
EPS next Q
-
EPS this Y
406.71%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
60.18%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-275674%
ROE
-200419%
ROC
-712.89%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.12-0.13
52W High
-
52W Low
-
RSI
-
Rel Volume
0.07
Avg Volume
18.16K
Volume
1.22K
Perf Week
0%
Perf Month
0%
Perf Quarter
-
Perf Half Y
0%
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.13
Change
-

Something similar

Top by Market Cap
MSF.DE
AMZN
VOO
FXAIX
0YXG.L
Same Sector
RPGLIFE.NS
3341.T
SPI.L
BVS
002688.SZ
Check Those
MWA
VEGA
RKDL.NS
600399.SS
IVCP
Similar Market Cap
ANKITMETAL.NS
2002.HK
JAR.L
600987.SS
6671.TW

Company Profile

Healthcare Medical - Diagnostics & Research

Accustem Sciences Limited engages in the genomic signature-based assay business for the prognosis of early and late recurrence of ER+/HER2 breast cancer in early stage breast cancer patients. The company was incorporated in 2020 and is based in London, the United Kingdom.